Changing the Shape of
Medical Research and Practice

Structurally and functionally
accurate bioprinted human tissue models

THERAPEUTIC TISSUES

Tomorrow

TISSUE TESTING SERVICES

Today

PRESS RELEASES

Organovo to Present New Preclinical Data on 3D Bioprinted Human Liver Tissues for the Treatment of Tyrosinemia I at the Liver Meeting® 2018 (AASLD) »

Organovo to Present at 2018 Cell & Gene Meeting on the Mesa »

INVESTOR INFORMATION

ONVO:

Organovo Holdings Inc

PRICE

1.10

CHANGE

0.00

Oct 16 2018 4:00PM

Data provided by Nasdaq.
Minimum 15 minutes delayed.

MENU